Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Other spotted fever group rickettsial infections

Daniel J Sexton, MD
Micah T McClain, MD
Section Editor
Stephen B Calderwood, MD
Deputy Editor
Jennifer Mitty, MD, MPH


Rickettsia of the spotted fever group (SFG) cause human disease on six continents (table 1). Although the antimicrobial treatment of all SFG infections is similar, important differences exist in the epidemiology, clinical features, and diagnostic methods of individual diseases caused by SFG rickettsiae (table 2). Millions of people now travel annually between continents and countries, and physicians who practice in areas far removed from the site of primary infection may face returning travelers with unusual or unfamiliar clinical illnesses that are due to SFG rickettsiae.

The epidemiology, clinical features, and treatment of infections due to SFG organisms other than Rickettsia rickettsii will be reviewed here. Rocky Mountain spotted fever (RMSF), caused by R. rickettsii, is discussed separately. (See "Clinical manifestations and diagnosis of Rocky Mountain spotted fever".)

Several human SFG rickettsiae have been identified in the past 16 years:

Rickettsia africae

Rickettsia felis

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Sep 12, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Walker DH. Rickettsiae and rickettsial infections: the current state of knowledge. Clin Infect Dis 2007; 45 Suppl 1:S39.
  2. Parola P, Paddock CD, Socolovschi C, et al. Update on tick-borne rickettsioses around the world: a geographic approach. Clin Microbiol Rev 2013; 26:657.
  3. Roux V, Raoult D. Phylogenetic analysis of the genus Rickettsia by 16S rDNA sequencing. Res Microbiol 1995; 146:385.
  4. Zhu Y, Fournier PE, Eremeeva M, Raoult D. Proposal to create subspecies of Rickettsia conorii based on multi-locus sequence typing and an emended description of Rickettsia conorii. BMC Microbiol 2005; 5:11.
  5. Fournier PE, Zhu Y, Yu X, Raoult D. Proposal to create subspecies of Rickettsia sibirica and an emended description of Rickettsia sibirica. Ann N Y Acad Sci 2006; 1078:597.
  6. Massung RF, Nicholson WL, Eremeeva ME, Dasch GA. On Rickettsia nomenclature. Emerg Infect Dis 2008; 14:511.
  7. Sekeyová Z, Fournier PE, Rehácek J, Raoult D. Characterization of a new spotted fever group rickettsia detected in Ixodes ricinus (Acari: Ixodidae) collected in Slovakia. J Med Entomol 2000; 37:707.
  8. Zhang JZ, Fan MY, Wu YM, et al. Genetic classification of "Rickettsia heilongjiangii" and "Rickettsia hulinii," two Chinese spotted fever group rickettsiae. J Clin Microbiol 2000; 38:3498.
  9. Higgins JA, Radulovic S, Schriefer ME, Azad AF. Rickettsia felis: a new species of pathogenic rickettsia isolated from cat fleas. J Clin Microbiol 1996; 34:671.
  10. Beeler E, Abramowicz KF, Zambrano ML, et al. A focus of dogs and Rickettsia massiliae-infected Rhipicephalus sanguineus in California. Am J Trop Med Hyg 2011; 84:244.
  11. McQuiston JH, Zemtsova G, Perniciaro J, et al. Afebrile spotted fever group Rickettsia infection after a bite from a Dermacentor variabilis tick infected with Rickettsia montanensis. Vector Borne Zoonotic Dis 2012; 12:1059.
  12. Raoult D, Roux V. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev 1997; 10:694.
  13. McDade JE. Evidence supporting the hypothesis that rickettsial virulence factors determine the severity of spotted fever and typhus group infections. Ann N Y Acad Sci 1990; 590:20.
  14. Jordan JM, Woods ME, Feng HM, et al. Rickettsiae-stimulated dendritic cells mediate protection against lethal rickettsial challenge in an animal model of spotted fever rickettsiosis. J Infect Dis 2007; 196:629.
  15. Font-Creus B, Bella-Cueto F, Espejo-Arenas E, et al. Mediterranean spotted fever: a cooperative study of 227 cases. Rev Infect Dis 1985; 7:635.
  16. Kass EM, Szaniawski WK, Levy H, et al. Rickettsialpox in a New York City hospital, 1980 to 1989. N Engl J Med 1994; 331:1612.
  17. Raoult D, Weiller PJ, Chagnon A, et al. Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases. Am J Trop Med Hyg 1986; 35:845.
  18. Rovery C, Brouqui P, Raoult D. Questions on Mediterranean spotted fever a century after its discovery. Emerg Infect Dis 2008; 14:1360.
  19. Sousa Rd, França A, Dória Nòbrega S, et al. Host- and microbe-related risk factors for and pathophysiology of fatal Rickettsia conorii infection in Portuguese patients. J Infect Dis 2008; 198:576.
  20. Pérez-de Pedro I, Macías-Vega N, Miranda-Candón I, Camps-García MT. [Severe Rickettsia conorii infection associated with hemophagocytic syndrome]. Enferm Infecc Microbiol Clin 2008; 26:597.
  21. Sexton DJ, Dwyer B, Kemp R, Graves S. Spotted fever group rickettsial infections in Australia. Rev Infect Dis 1991; 13:876.
  22. Sexton DJ, King G, Dwyer B. Fatal Queensland tick typhus. J Infect Dis 1990; 162:779.
  23. Stewart RS. Flinders Island spotted fever: a newly recognised endemic focus of tick typhus in Bass Strait. Part 1. Clinical and epidemiological features. Med J Aust 1991; 154:94.
  24. Stenos J, Roux V, Walker D, Raoult D. Rickettsia honei sp. nov., the aetiological agent of Flinders Island spotted fever in Australia. Int J Syst Bacteriol 1998; 48 Pt 4:1399.
  25. Unsworth NB, Stenos J, Graves SR, et al. Flinders Island spotted fever rickettsioses caused by "marmionii" strain of Rickettsia honei, Eastern Australia. Emerg Infect Dis 2007; 13:566.
  26. Jiang J, Sangkasuwan V, Lerdthusnee K, et al. Human Infection with Rickettsia honei, Thailand. Emerg Infect Dis 2005; 11:1473.
  27. Parola P, Miller RS, McDaniel P, et al. Emerging rickettsioses of the Thai-Myanmar border. Emerg Infect Dis 2003; 9:592.
  28. Murphy H, Renvoise A, Pandey P, et al. Rickettsia honei infection in human, Nepal, 2009. Emerg Infect Dis 2011; 17:1865.
  29. Pijper A. Tick bite fever. S Afr Med J 1934; 11:551.
  30. Kelly PJ, Mason PR. Serological typing of spotted fever group Rickettsia isolates from Zimbabwe. J Clin Microbiol 1990; 28:2302.
  31. Jensenius M, Fournier PE, Fladby T, et al. Sub-acute neuropathy in patients with African tick bite fever. Scand J Infect Dis 2006; 38:114.
  32. Fournier PE, Roux V, Caumes E, et al. Outbreak of Rickettsia africae infections in participants of an adventure race in South Africa. Clin Infect Dis 1998; 27:316.
  33. Owen CE, Bahrami S, Malone JC, et al. African tick bite fever: a not-so-uncommon illness in international travelers. Arch Dermatol 2006; 142:1312.
  34. Raoult D, Fournier PE, Fenollar F, et al. Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa. N Engl J Med 2001; 344:1504.
  35. Jensenius M, Fournier PE, Raoult D. Rickettsioses and the international traveler. Clin Infect Dis 2004; 39:1493.
  36. Lewin MR, Bouyer DH, Walker DH, Musher DM. Rickettsia sibirica infection in members of scientific expeditions to northern Asia. Lancet 2003; 362:1201.
  37. Yu X, Jin Y, Fan M, et al. Genotypic and antigenic identification of two new strains of spotted fever group rickettsiae isolated from China. J Clin Microbiol 1993; 31:83.
  38. Fournier PE, Tissot-Dupont H, Gallais H, Raoult DR. Rickettsia mongolotimonae: a rare pathogen in France. Emerg Infect Dis 2000; 6:290.
  39. Raoult D, Brouqui P, Roux V. A new spotted-fever-group rickettsiosis. Lancet 1996; 348:412.
  40. Caron J, Rolain JM, Mura F, et al. Rickettsia sibirica subsp. mongolitimonae infection and retinal vasculitis. Emerg Infect Dis 2008; 14:683.
  41. Fournier PE, Gouriet F, Brouqui P, et al. Lymphangitis-associated rickettsiosis, a new rickettsiosis caused by Rickettsia sibirica mongolotimonae: seven new cases and review of the literature. Clin Infect Dis 2005; 40:1435.
  42. Mahara F, Koga K, Sawada S, et al. [The first report of the rickettsial infections of spotted fever group in Japan: three clinical cases]. Kansenshogaku Zasshi 1985; 59:1165.
  43. Gaywee J, Sunyakumthorn P, Rodkvamtook W, et al. Human infection with Rickettsia sp. related to R. japonica, Thailand. Emerg Infect Dis 2007; 13:671.
  44. Mahara F. Japanese spotted fever: report of 31 cases and review of the literature. Emerg Infect Dis 1997; 3:105.
  45. Nomura T, Fujimoto T, Ebisutani C, et al. The first fatal case of Japanese spotted fever confirmed by serological and microbiological tests in Awaji Island, Japan. Jpn J Infect Dis 2007; 60:241.
  46. Azad AF, Sacci JB Jr, Nelson WM, et al. Genetic characterization and transovarial transmission of a typhus-like rickettsia found in cat fleas. Proc Natl Acad Sci U S A 1992; 89:43.
  47. Galvão MA, Zavala-Velazquez JE, Zavala-Castro JE, et al. Rickettsia felis in the Americas. Ann N Y Acad Sci 2006; 1078:156.
  48. Parola P, Davoust B, Raoult D. Tick- and flea-borne rickettsial emerging zoonoses. Vet Res 2005; 36:469.
  49. Schriefer ME, Sacci JB Jr, Dumler JS, et al. Identification of a novel rickettsial infection in a patient diagnosed with murine typhus. J Clin Microbiol 1994; 32:949.
  50. Raoult D, Lakos A, Fenollar F, et al. Spotless rickettsiosis caused by Rickettsia slovaca and associated with Dermacentor ticks. Clin Infect Dis 2002; 34:1331.
  51. Ibarra V, Oteo JA, Portillo A, et al. Rickettsia slovaca infection: DEBONEL/TIBOLA. Ann N Y Acad Sci 2006; 1078:206.
  52. Paddock CD, Sumner JW, Comer JA, et al. Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis 2004; 38:805.
  53. Whitman TJ, Richards AL, Paddock CD, et al. Rickettsia parkeri infection after tick bite, Virginia. Emerg Infect Dis 2007; 13:334.
  54. Pacheco RC, Venzal JM, Richtzenhain LJ, Labruna MB. Rickettsia parkeri in Uruguay. Emerg Infect Dis 2006; 12:1804.
  55. Silveira I, Pacheco RC, Szabó MP, et al. Rickettsia parkeri in Brazil. Emerg Infect Dis 2007; 13:1111.
  56. Chen LH, Wilson ME. Tick-borne rickettsiosis in traveler returning from Honduras. Emerg Infect Dis 2009; 15:1321.
  57. Paddock CD, Finley RW, Wright CS, et al. Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. Clin Infect Dis 2008; 47:1188.
  58. Straily A, Feldpausch A, Ulbrich C, et al. Notes from the Field: Rickettsia parkeri Rickettsiosis - Georgia, 2012-2014. MMWR Morb Mortal Wkly Rep 2016; 65:718.
  59. Herrick KL, Pena SA, Yaglom HD, et al. Rickettsia parkeri Rickettsiosis, Arizona, USA. Emerg Infect Dis 2016; 22:780.
  60. Raoult D. A new rickettsial disease in the United States. Clin Infect Dis 2004; 38:812.
  61. Apperson CS, Engber B, Nicholson WL, et al. Tick-borne diseases in North Carolina: is "Rickettsia amblyommii" a possible cause of rickettsiosis reported as Rocky Mountain spotted fever? Vector Borne Zoonotic Dis 2008; 8:597.
  62. Vaughn MF, Delisle J, Johnson J, et al. Seroepidemiologic study of human infections with spotted fever group Rickettsiae in North Carolina. J Clin Microbiol 2014; 52:3960.
  63. Shapiro MR, Fritz CL, Tait K, et al. Rickettsia 364D: a newly recognized cause of eschar-associated illness in California. Clin Infect Dis 2010; 50:541.
  64. Johnston SH, Glaser CA, Padgett K, et al. Rickettsia spp. 364D causing a cluster of eschar-associated illness, California. Pediatr Infect Dis J 2013; 32:1036.
  65. Padgett KA, Bonilla D, Eremeeva ME, et al. The Eco-epidemiology of Pacific Coast Tick Fever in California. PLoS Negl Trop Dis 2016; 10:e0005020.
  66. La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 1997; 35:2715.
  67. Radulovic S, Speed R, Feng HM, et al. EIA with species-specific monoclonal antibodies: a novel seroepidemiologic tool for determination of the etiologic agent of spotted fever rickettsiosis. J Infect Dis 1993; 168:1292.
  68. Fournier PE, Raoult D. Suicide PCR on skin biopsy specimens for diagnosis of rickettsioses. J Clin Microbiol 2004; 42:3428.
  69. Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States. MMWR Recomm Rep 2016; 65:1.
  70. Botelho-Nevers E, Rovery C, Richet H, Raoult D. Analysis of risk factors for malignant Mediterranean spotted fever indicates that fluoroquinolone treatment has a deleterious effect. J Antimicrob Chemother 2011; 66:1821.
  71. Raoult D. Antibiotic treatment of rickettsiosis, recent advances and current concepts. Eur J Epidemiol 1991; 7:276.
  72. Ruiz Beltrán R, Herrero Herrero JI. Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever. Eur J Clin Microbiol Infect Dis 1992; 11:427.
  73. Lochary ME, Lockhart PB, Williams WT Jr. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 1998; 17:429.
  74. Todd SR, Dahlgren FS, Traeger MS, et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. J Pediatr 2015; 166:1246.
  75. Jang HC, Choi SM, Jang MO, et al. Inappropriateness of quinolone in scrub typhus treatment due to gyrA mutation in Orientia tsutsugamushi Boryong strain. J Korean Med Sci 2013; 28:667.
  76. American Academy of Pediatrics (AAP). Red Book: 2012 Report of the Committee on Infectious Diseases, 29, Pickering LK, Baker CJ, Kimberlin DW, Long SS (Eds), American Academy of Pediatrics, Elk Grove, IL 2012.
  77. Cascio A, Colomba C, Antinori S, et al. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. Clin Infect Dis 2002; 34:154.
  78. Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006; 55:1.
  79. Cross R, Ling C, Day NP, et al. Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation? Expert Opin Drug Saf 2016; 15:367.
  80. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol 2009; 23:18.
  81. Wiest DB, Cochran JB, Tecklenburg FW. Chloramphenicol toxicity revisited: a 12-year-old patient with a brain abscess. J Pediatr Pharmacol Ther 2012; 17:182.
  82. Powell DA, Nahata MC. Chloramphenicol: new perspectives on an old drug. Drug Intell Clin Pharm 1982; 16:295.
  83. McGready R, Prakash JA, Benjamin SJ, et al. Pregnancy outcome in relation to treatment of murine typhus and scrub typhus infection: a fever cohort and a case series analysis. PLoS Negl Trop Dis 2014; 8:e3327.